These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 37591588)
1. The effect of a comprehensive typhoid conjugate vaccine campaign on antimicrobial prescribing in children in Harare, Zimbabwe: a mixed methods study. Olaru ID; Chingono RMS; Bottomley C; Kandiye FR; Mhino F; Nyamayaro CA; Manyau S; Vere M; Chitando P; Chonzi P; Darton TC; Dixon J; Kranzer K Lancet Glob Health; 2023 Sep; 11(9):e1422-e1431. PubMed ID: 37591588 [TBL] [Abstract][Full Text] [Related]
2. Population structure of Salmonella enterica Typhi in Harare, Zimbabwe (2012-19) before typhoid conjugate vaccine roll-out: a genomic epidemiology study. Thilliez G; Mashe T; Chaibva BV; Robertson V; Bawn M; Tarupiwa A; Takawira FT; Kock MM; Midzi S; Mwamakamba LW; Matheu J; Juru A; Kingsley RA; Ehlers MM Lancet Microbe; 2023 Dec; 4(12):e1005-e1014. PubMed ID: 37952554 [TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial. Kumar Rai G; Saluja T; Chaudhary S; Tamrakar D; Kanodia P; Giri BR; Shrestha R; Uranw S; Kim DR; Yang JS; Park IY; Kyung SE; Vemula S; Reddy E J; Kim B; Gupta BP; Jo SK; Ryu JH; Park HK; Shin JH; Lee Y; Kim H; Kim JH; Mojares ZR; Wartel TA; Sahastrabuddhe S Lancet Infect Dis; 2022 Apr; 22(4):529-540. PubMed ID: 34942090 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study. Yousafzai MT; Karim S; Qureshi S; Kazi M; Memon H; Junejo A; Khawaja Z; Ur Rehman N; Ansari MS; Ali R; Ujjan IU; Lohana HM; Memon NM; Hussain M; Nigar R; Bar-Zeev N; Qamar FN Lancet Glob Health; 2021 Aug; 9(8):e1154-e1162. PubMed ID: 34297962 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study. Lightowler MS; Manangazira P; Nackers F; Van Herp M; Phiri I; Kuwenyi K; Panunzi I; Garone D; Marume F; Tarupiwa A; Ferreras E; Duri C; Luquero FJ Vaccine; 2022 Jul; 40(31):4199-4210. PubMed ID: 35690501 [TBL] [Abstract][Full Text] [Related]
6. Enhanced surveillance for adverse events following immunization during the 2019 typhoid conjugate vaccine campaign in Harare, Zimbabwe. Shaum A; Mujuru HA; Takamiya M; Ticklay I; Nathoo K; Sreenivasan N; Nyambayo P; Chitando P; Marembo J; Koline Chigodo C; Mukaratirwa A; Jacha V; Gidudu JF; Rupfutse M; Kumar Jain S; Manangazira P; Bennett SD Vaccine; 2022 Jun; 40(26):3573-3580. PubMed ID: 35568590 [TBL] [Abstract][Full Text] [Related]
7. Field evaluation of typhoid conjugate vaccine in a catch-up campaign among children aged 9 months to 15 years in Sindh, Pakistan. Thobani RS; Yousafzai MT; Sultana S; Kazi AM; Jan M; Rafey A; Khan A; Irfan S; Ujjan IU; Brown N; Mårtensson A; Qamar FN Vaccine; 2022 Aug; 40(36):5391-5398. PubMed ID: 35945044 [TBL] [Abstract][Full Text] [Related]
8. Vaccines for preventing typhoid fever. Milligan R; Paul M; Richardson M; Neuberger A Cochrane Database Syst Rev; 2018 May; 5(5):CD001261. PubMed ID: 29851031 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial. Shakya M; Voysey M; Theiss-Nyland K; Colin-Jones R; Pant D; Adhikari A; Tonks S; Mujadidi YF; O'Reilly P; Mazur O; Kelly S; Liu X; Maharjan A; Dahal A; Haque N; Pradhan A; Shrestha S; Joshi M; Smith N; Hill J; Clarke J; Stockdale L; Jones E; Lubinda T; Bajracharya B; Dongol S; Karkey A; Baker S; Dougan G; Pitzer VE; Neuzil KM; Shrestha S; Basnyat B; Pollard AJ; Lancet Glob Health; 2021 Nov; 9(11):e1561-e1568. PubMed ID: 34678198 [TBL] [Abstract][Full Text] [Related]
10. The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial. Kulkarni PS; Potey AV; Bharati S; Kunhihitlu A; Narasimha B; Yallapa S; Dharmadhikari A; Gavade V; Kamat CD; Mallya A; Sarma AD; Goel S; Pisal SS; Poonawalla CS; Venkatesan R; Jones E; Flaxman A; Kim YC; Pollard AJ; Lancet; 2024 Apr; 403(10436):1554-1562. PubMed ID: 38555928 [TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study. Mohan VK; Varanasi V; Singh A; Pasetti MF; Levine MM; Venkatesan R; Ella KM Clin Infect Dis; 2015 Aug; 61(3):393-402. PubMed ID: 25870324 [TBL] [Abstract][Full Text] [Related]
12. Prospects of Future Typhoid and Paratyphoid Vaccines in Endemic Countries. Shakya M; Neuzil KM; Pollard AJ J Infect Dis; 2021 Dec; 224(12 Suppl 2):S770-S774. PubMed ID: 34374785 [TBL] [Abstract][Full Text] [Related]
13. Implementation of an outbreak response vaccination campaign with typhoid conjugate vaccine - Harare, Zimbabwe, 2019. Poncin M; Marembo J; Chitando P; Sreenivasan N; Makwara I; Machekanyanga Z; Nyabyenda W; Mukeredzi I; Munyanyi M; Hidle A; Chingwena F; Chigwena C; Atuhebwe P; Matzger H; Chigerwe R; Shaum A; Date K; Garone D; Chonzi P; Barak J; Phiri I; Rupfutse M; Masunda K; Gasasira A; Manangazira P Vaccine X; 2022 Dec; 12():100201. PubMed ID: 35983519 [TBL] [Abstract][Full Text] [Related]
14. Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study. Birger R; Antillón M; Bilcke J; Dolecek C; Dougan G; Pollard AJ; Neuzil KM; Frost I; Laxminarayan R; Pitzer VE Lancet Infect Dis; 2022 May; 22(5):679-691. PubMed ID: 35123673 [TBL] [Abstract][Full Text] [Related]
15. Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance. Andrews JR; Baker S; Marks F; Alsan M; Garrett D; Gellin BG; Saha SK; Qamar FN; Yousafzai MT; Bogoch II; Antillon M; Pitzer VE; Kim JH; John J; Gauld J; Mogasale V; Ryan ET; Luby SP; Lo NC Lancet Infect Dis; 2019 Jan; 19(1):e26-e30. PubMed ID: 30170987 [TBL] [Abstract][Full Text] [Related]
16. Typhoid Conjugate Vaccines: Advancing the Research and Public Health Agendas. Birkhold M; Mwisongo A; Pollard AJ; Neuzil KM J Infect Dis; 2021 Dec; 224(12 Suppl 2):S781-S787. PubMed ID: 34528085 [TBL] [Abstract][Full Text] [Related]
17. Decision Making and Implementation of the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018. Date K; Shimpi R; Luby S; N R; Haldar P; Katkar A; Wannemuehler K; Mogasale V; Pallas S; Song D; Kunwar A; Loharikar A; Yewale V; Ahmed D; Horng L; Wilhelm E; Bahl S; Harvey P; Dutta S; Bhatnagar P Clin Infect Dis; 2020 Jul; 71(Suppl 2):S172-S178. PubMed ID: 32725235 [TBL] [Abstract][Full Text] [Related]